Related pilotsAll pilots
Exalenz – Grupo Fleury
Exalenz‘s BreathID® Lab System senses CO2 in exhaled breath and analyzes its different isotopes in real-time
Combinostics – Grupo Fleury/Hospital Sirio Libanês
Combinostics' cloud-based platform with machine-learning tools, called cNeuro, enables quantitative assessment of brain images and provides clinical decision support for neurological disorders. In this pilot, Grupo Fleury and Hospital Sirio Libanês, in collaboration with the Department of Radiology and Oncology of Faculdade de Medicina da Universidade de São Paulo (USP), will use the cNeuro AI platform to analyze Alzheimer's disease and other forms of dementia and the specificities applicable in the Brazilian market.